Marinus Pharmaceuticals Stock Quote MRNS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.54

Bid

1.50

Ask

1.54

Volume

384,898

1.48 Day's Range 1.55

1.11 52 Week Range 11.26

Market Cap

81.964M

Previous Close

1.54

Open

1.55

Last Trade

1.54

Last Trade Time

Financial Volume

$ 580,804

VWAP

1.509

Average Volume (3m)

2,225,634

Shares Outstanding

54,642,580

Dividend Yield

PE Ratio

-0.58

Earnings Per Share (EPS)

-2.59

Revenue

30.99M

Net Profit

-141.41M

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychi... Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.marinuspharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Marinus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRNS. The last closing price for Marinus Pharmaceuticals was $1.54. Over the last year, Marinus Pharmaceuticals shares have traded in a share price range of $ 1.11 to $ 11.26.

Marinus Pharmaceuticals currently has 54,642,580 shares outstanding. The market capitalization of Marinus Pharmaceuticals is $81.96 million. Marinus Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.58.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	1.54	1.585	1.4	901599	1.46730681	CS
4	0.04	2.66666666667	1.5	1.585	1.27	1216220	1.3883253	CS
12	-7.91	-83.7037037037	9.45	9.69	1.11	2225634	2.00463017	CS
26	-6.51	-80.8695652174	8.05	11.26	1.11	1267181	3.43137208	CS
52	-5.94	-79.4117647059	7.48	11.26	1.11	972094	5.14221783	CS
156	-15.02	-90.7004830918	16.56	19.83	1.11	557340	6.33655793	CS
260	-3.07	-66.5943600868	4.61	20.04	0.77	1039555	4.43659569	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VRAXVirax Biolabs Group Ltd	$ 1.96 (83.18%)	79.77M
TOIIWOncology Institute Inc	$ 0.0293 (75.45%)	7.55k
FBLGFibroBiologics Inc	$ 10.39 (55.07%)	2.93M
SHOTWSafety Shot Inc	$ 0.3799 (46.12%)	597
TRSGTungray Technologies Inc	$ 4.70 (42.86%)	278.54k
CNSPCNS Pharmaceuticals Inc	$ 5.20 (-98.07%)	168.18k
PLTNPlutoniam Acquisition Corporation	$ 2.41 (-58.45%)	961.3k
PLTNUPlutoniam Acquisition Corporation	$ 2.94 (-57.08%)	5.48k
ASNSActelis Networks Inc	$ 1.9899 (-46.51%)	8.61M
ICUSeaStar Medical Holding Corporation	$ 0.2141 (-39.52%)	10.73M
KITTNauticus Robotics Inc	$ 0.167 (21.01%)	238.1M
FRGTFreight Technologies Inc	$ 0.6899 (10.38%)	221.72M
FFIEFaraday Future Intelligent Electric Inc	$ 0.5449 (2.52%)	167.59M
SQQQProShares UltraPro Short QQQ	$ 9.29 (0.32%)	97.48M
AEMDAethlon Medical Inc	$ 0.560256 (27.74%)	95.69M